All In Biotech

Drug Trial Radar · NCT07891377

HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid Malignancies

A Multicenter, Randomized, Open-label, Positive-controlled Phase 2 Clinical Trial of HEC53856 Tablets Versus Recombinant Human Erythropoietin Injection in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Feb 2028

Study completion May 2029

Sponsor

Lead sponsor
Sunshine Lake Pharma Co., Ltd.Industry
Sponsor type
Industry
First posted
Oct 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase II clinical trial to evaluate the efficacy and safety of different dosing regimens of HEC53856 tablets compared to rHuEPO injection in participants of the CIA trial.

Conditions

  • Chemotherapy-induced Anemia
  • Non-Myeloid Malignancy

Interventions

  • HEC53856 tabletDrug

    The experimental cohort is divided into four groups: 20 mg once a day (QD) group, 40 mg QD group, 60 mg QD group, and 100 mg three times a week \[TIW\] group. Participants in the experimental cohort will take HEC53856 tablets orally either in the fasted state or after meals.

  • rHuEPO injectionDrug

    rHuEPO Injection 36000 IU will be subcutaneously administered once weekly \[QW\].

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The compliance rate of hemoglobin (Hb) in trial participants at week 7Time frame: Week 7

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Chest Hospital

    Shanghai, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.